Conference Coverage

Sepsis response team does not improve mortality/organ dysfunction


 

FROM CHEST 2017

A sepsis response team did not have a positive effect on mortality or organ dysfunction in septic patients, compared with standard treatment by a primary care team, according to a study abstract scheduled to be presented at CHEST 2017.

a scene from an emergency dept., with people rushing and a patient on a stretcher DigitalVision/Thinkstock
The study covers a retrospective analysis of 517 septic patients in an inpatient ward at a tertiary care academic center from June 2014 until December 2016. Of this group, 302 were treated by a sepsis response team, while the others were treated by the normal primary care team.

Compared with the primary care team, the sepsis team was more likely to intervene on patients with a quick Sepsis-Related Organ Failure Assessment score greater than 1 (33.8% vs. 22.8%), change or initiate antibiotics within 3 hours (64.6% vs. 37.2%), and obtain blood cultures on time (66.4% vs 45.2%). An additional difference between the two groups was that the sepsis team had better compliance with the 3-hour bundle (15.2% vs 8.4%).

Despite the sepsis team’s higher level of compliance with certain protocols, the combined outcome measure of mortality and organ dysfunction within 28 days was not significantly higher for patients treated by the sepsis team (11.3% vs. 9.8%; P = .6). In fact, there was at least one downside to being treated by the sepsis team, which was having a 14% longer hospital stay.

Chhaya Patel, MD, is scheduled to present the abstract on Sun., Oct. 29th, at 2:30-2:45 p.m. in Convention Center – 602B. This research is part of the Sepsis & Septic Shock session at the CHEST annual meeting, which will run from 1:30 to 3:00 p.m.

Recommended Reading

Small study advances noninvasive ICP monitoring
MDedge Internal Medicine
End-of-life advice: More than 500,000 chat on Medicare’s dime
MDedge Internal Medicine
PVC phlebitis rates varied widely, depending on assessment tool
MDedge Internal Medicine
No benefit seen for routine low-dose oxygen after stroke
MDedge Internal Medicine
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
MDedge Internal Medicine
VA study finds high MRSA infection risk among those colonized with the bacterium
MDedge Internal Medicine
Negative nasal swabs reliably predicted no MRSA infection
MDedge Internal Medicine
Wait at least 2 days to replace central venous catheters in patients with candidemia
MDedge Internal Medicine
Ideal intubation position still unknown
MDedge Internal Medicine
RBCs from previously pregnant women linked to increased mortality in men
MDedge Internal Medicine